ICD-10 Diagnosis Code T80.89XD

Oth comp fol infusion, transfuse and theraputc inject, subs

Diagnosis Code T80.89XD

ICD-10: T80.89XD
Short Description: Oth comp fol infusion, transfuse and theraputc inject, subs
Long Description: Other complications following infusion, transfusion and therapeutic injection, subsequent encounter
This is the 2018 version of the ICD-10-CM diagnosis code T80.89XD

Valid for Submission
The code T80.89XD is valid for submission for HIPAA-covered transactions.

Code Classification
  • Injury, poisoning and certain other consequences of external causes (S00–T98)
    • Complications of surgical and medical care, not elsewhere classified (T80-T88)
      • Comp following infusion, transfusion and theraputc injection (T80)

Information for Medical Professionals

Diagnostic Related Groups
The diagnosis code T80.89XD is grouped in the following Diagnostic Related Group(s) (MS-DRG V35.0)


Convert to ICD-9 Additional informationCallout TooltipGeneral Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

Present on Admission (POA) Additional informationCallout TooltipPresent on Admission
The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement.

The code T80.89XD is exempt from POA reporting.

  • Abdominal hernia as complication of peritoneal dialysis
  • Acute disorder of hemodialysis
  • Acute disorder of hemodialysis
  • Acute disorder of hemodialysis
  • Acute megaloblastic anemia
  • Acute megaloblastic anemia
  • Acute megaloblastic anemia due to dialysis
  • Acute megaloblastic anemia secondary to total parenteral nutrition
  • Adynamic bone disease
  • Allergic transfusion reaction
  • Alloimmune platelet transfusion refractoriness
  • Alloimmune thrombocytopenia
  • Anaphylactoid reaction to dialysis
  • Bloodstained peritoneal dialysis effluent
  • Complication of injection
  • Complication of introduction procedure
  • Dialysis dementia
  • Dialysis disequilibrium syndrome
  • Dialysis fluid adverse reaction
  • Dialysis membrane-induced anaphylactoid reaction
  • Dialysis-associated ascites
  • Dialysis-associated hypoxia
  • Encapsulating peritoneal sclerosis associated with peritoneal dialysis
  • Erythema at injection site
  • Erythrocytosis due to autotransfusion
  • Extravasation following blood transfusion
  • Extravasation injury
  • First use syndrome of dialysis
  • Hematoma of dialysis access site
  • Hemodialysis fluid adverse reaction
  • Hemodialysis-associated pruritus
  • Hemodialysis-associated pseudoporphyria
  • Hemofiltration solution adverse reaction
  • Hemolytic transfusion reaction
  • Hemoperitoneum as complication of peritoneal dialysis
  • Hemorrhage into peritoneal cavity
  • Hemosiderosis
  • Hydrothorax
  • Hydrothorax as complication of peritoneal dialysis
  • Hypercalcemia associated with chronic dialysis
  • Hyperchloremic acidosis associated with dialysis
  • Inadequate hemodialysis
  • Inadequate peritoneal dialysis
  • Induration at injection site
  • Injection neuropathy
  • Injection site anesthesia
  • Injection site atrophy
  • Injection site bruising
  • Injection site burning
  • Injection site cyst
  • Injection site dermatitis
  • Injection site edema
  • Injection site fibrosis
  • Injection site hemorrhage
  • Injection site hypersensitivity
  • Injection site induration
  • Injection site inflammation
  • Injection site irritation
  • Injection site malabsorption
  • Injection site mass
  • Injection site mass
  • Injection site necrosis
  • Injection site nerve damage
  • Injection site pain
  • Injection site paresthesia
  • Injection site pigmentation change
  • Injection site thrombosis
  • Injection site urticaria
  • Intravasation of drug or medicament
  • Lipoatrophy
  • Lipoatrophy caused by injected drug
  • Lipogranuloma
  • Localized adverse reaction caused by administration of drug
  • Localized lipoatrophy
  • Long-term disorder of dialysis
  • Loss of solute clearance
  • Megaloblastic anemia due to hemodialysis
  • Megaloblastic anemia due to total parenteral nutrition
  • Metabolic acidosis, normal anion gap, acidifying salts
  • Nontraumatic hemoperitoneum
  • Pain during inflow of dialysate
  • Pain during outflow of dialysate
  • Penile sclerosing lipogranuloma
  • Penile sclerosing lipogranuloma caused by injected substance
  • Peritoneal dialysis solution adverse reaction
  • Pseudoporphyria
  • Pulmonary transfusion reaction
  • Sclerosing lipogranuloma
  • Sclerosing peritonitis
  • Sclerosing peritonitis as complication of peritoneal dialysis
  • Skin lesion associated with hemodialysis
  • Skin lesion associated with hemodialysis
  • Swelling at injection site
  • Thrombocytopenia due to extracorporeal circulation of blood
  • Thromboembolism following infusion, perfusion AND/OR transfusion
  • Transfusion hemosiderosis
  • Transfusion reaction caused by toxic effect of anticoagulant
  • Transfusion reaction caused by toxic substance in blood
  • Transfusion reaction due to products of cell metabolism
  • Underdialysis
  • Urticarial transfusion reaction

Previous Code
Previous Code T80.89XA
Next Code
T80.89XS Next Code